HCA Healthcare (HCA +0.3%) announces that
172 of its affiliated hospitals have joined a nationwide study
evaluating the efficacy of convalescent plasma in COVID-19 patients.
Convalescent plasma, collected from people who
recovered from COVID-19 infection and have antibodies against the
coronavirus, has shown potential in helping sick patients.
The main challenge is sourcing enough product. HCA says it is seeking qualified donors in 20 states.
https://seekingalpha.com/news/3564188-hca-joins-convalescent-plasma-study
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.